Latest News
Higher HCV Rates, Lower Buprenorphine Prescriptions in Rural Counties in Ohio
Cytomegalovirus Risk Higher With Immunosuppressive Treatment for Systemic Lupus Erythematosus
Risk Factors Associated With Worse COVID-19 Outcomes in Pregnancy
Privacy Concerns Examined Regarding Use of Mobile Health Apps
U.S. to Spend $3.2 Billion to Help Develop Antiviral Pills for COVID-19
Tuberculosis Outbreak May Be Linked to Bone Repair Product
Obesity Tied to Long-Term COVID-19 Complications
Islatravir Plus Doravirine: New Potent HIV-1 Regimen Warrants Further Development
Bamlanivimab Monotherapy Improves Hospitalization, Mortality Outcomes in COVID-19
Early De-escalation to Fluconazole for Fluconazole-Susceptible Candidemia
High Burden of Age-Related Non-AIDS Comorbidities Among Women Living With HIV
Ahead of Tokyo Olympics, Japan Eases COVID-19 Restrictions
Red Cross Warns of Severe Blood Shortage
Latest Features & Opinion
WHO Global Initiative Highlights the Negative Health Effects of Ageism
“Ageism is one of the most socially condoned and institutionalized forms of prejudice in the United States.”
Multispecialty Perspectives on Long COVID-19
Experts in infectious disease, pulmonology, cardiology, neurology, and psychiatry share their perspectives on the phenomenon that is long COVID-19.
Monoclonal Antibodies for COVID-19: Expert Insights
The IDSA recommends that antibody therapy should be administered to patients with mild to moderate COVID-19 at high risk for progression to severe disease.
ACP Releases Practice Advice for Short-Course Antibiotics in Common Infections
The American College of Physicians convened a panel to identify best practices for the use of short-course antibiotics in the management of common infections.
- Loading...
Loading...
Loading... 
Loading...